Research Publications

Back

Potentially actionable FGFR2 high-level amplification in thymic sebaceous carcinoma


Porubsky, S; Jessup, P; Kee, D; Sharma, R; OCHI, A; Xu, H; Froelich, JJ; Nott, L; Scott, C; Awad, R; Moldovan, C; Hardikar, AA; Bohnenberger, H; Kuffer, S; Strobel, P; Marx, A
2020-02
2019-08-10
Virchows Archiv
Journal Article
476
2
323-327
Our aim was to investigate sebaceous differentiation in thymus tumours and to identify new actionable genomic alterations. To this end we screened 35 normal and 23 hyperplastic thymuses, 127 thymomas and 41 thymic carcinomas for the presence of sebaceous differentiation as defined by morphology and expression of adipophilin and androgen receptor (AR). One primary thymic carcinoma showed morphology of sebaceous carcinomas (keratinizing and foam cells, calcifications, giant cells), a strong expression of adipophilin and AR together with squamous markers. NGS revealed high-level amplification of fibroblast growth factor receptor 2 (FGFR2). In thymuses and thymomas, no cells with sebaceous morphology were present. Occasionally, macrophages or epithelial cells showed adipophilin-positivity, however, without co-expression of AR. Thymic sebaceous carcinoma should be considered if a thymic carcinoma shows clear or foamy features. Testing for FGFR2 amplification might be warranted when searching for actionable genomic alterations in sebaceous carcinomas in the mediastinum and in other locations.
Springer
Cancer Biology and Stem Cells
10.1007/s00428-019-02644-3
31401665
Refer to copyright notice on published article.

Back
Creation Date 2019-08-13 12:35:08 Last Modified 2020-04-02 02:16:17